Cathie Wood's ARK Invest Sells Over 125,000 Shares of Iovance Bio

Investing

Published: August 26, 2021 8:45 am

One of the ARK exchange-traded funds run by ETF star Cathie Wood made huge sale on Wednesday. This fund sold over 125,000 shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares, as the price of this ETF was flat on Wednesday. Note that this ETF is still up handily in the past year.

ARK Innovation ETF (NYSEARCA: ARKK) sold 128,163 shares of Iovance. At Wednesday’s closing price, this would have valued this sale at $3 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 37% in the past year.

Check out all of the ARK Invest sales for Wednesday:

Fund	Ticker	Name	Shares
ARKF	3690HK	MEITUAN	1,342,426
ARKF	9923HK	YEAHKA	339,600
ARKF	6060HK	ZHONGAN ONLINE P&C INSURANCE	1,339,400
ARKG	SEER	SEER	152,557
ARKG	RHHBY	ROCHE	66,000
ARKG	PSTI	PLURISTEM THERAPEUTICS	16,223
ARKG	BMY	BRISTOL-MYERS SQUIBB	114,400
ARKK	IOVA	IOVANCE BIOTHERAPEUTICS	128,163
ARKK	NTDOY	NINTENDO	53,300
ARKQ	XONE	EXONE	82,333
ARKW	LC	LENDINGCLUB	164,932
ARKW	NFLX	NETFLIX	192

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

24/7 Wall St.
Goldman Sachs Says Buy These 4 Top Oil Stocks With Huge 2022 Upside Potential

Are You Ahead, or Behind on Retirement? (sponsor)

If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention. Many people have worked their whole lives preparing to retire without ever knowing the answer to the most important question: are you ahead, or behind on your retirement goals?

Don’t make the same mistake. It’s an easy question to answer. A quick conversation with a financial advisor can help you unpack your savings, spending, and goals for your money. With SmartAsset’s free tool, you can connect with vetted financial advisors in minutes.

Why wait? Click here to get started today!